Effects of Cyclic Adenosine Monophosphate, Dexamethasone and Insulin on Phosphoenolpyruvate Carboxykinase Synthesis in Reuber H-35 Hepatoma Cells

J. Martyn Gunn, Shirley M. Tilghman, Richard W. Hanson, Lea Reshef, F. John Ballard

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Antiserum prepared against rat liver cytosolic phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) is shown to specifically precipitate the enzyme from Reuber H-35 cells. Synthesis of phosphoenolpyruvate carboxykinase, as measured immunochemically, is increased by dibutyryl cAMP and dexamethasone, the nucleotide maximally producing a sixfold and the glucocorticoid a threefold change in rate. Studies with actinomycin D, cordycepin, and cycloheximide suggest dibutyryl cAMP acts at a translational or post-transcriptional site. Insulin prevents the increase in synthesis of phosphoenolpyruvate carboxykinase produced by either dibutyryl cAMP or dexamethasone. This antagonism is concentration dependent and does not require the simultaneous presence of glucose, pointing to a direct effect of the hormone on liver enzyme induction. It is suggested that hepatic phosphoenolpyruvate carboxykinase activity is regulated predominantly by the antagonistic interaction of cAMP (glucagon) and insulin on enzyme synthesis.

Original languageEnglish (US)
Pages (from-to)2350-2357
Number of pages8
JournalBiochemistry
Volume14
Issue number11
DOIs
StatePublished - Jun 1 1975
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Biochemistry

Fingerprint Dive into the research topics of 'Effects of Cyclic Adenosine Monophosphate, Dexamethasone and Insulin on Phosphoenolpyruvate Carboxykinase Synthesis in Reuber H-35 Hepatoma Cells'. Together they form a unique fingerprint.

Cite this